These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33341360)

  • 21. Single-center experience with use of letermovir for CMV prophylaxis or treatment in thoracic organ transplant recipients.
    Aryal S; Katugaha SB; Cochrane A; Brown AW; Nathan SD; Shlobin OA; Ahmad K; Marinak L; Chun J; Fregoso M; Desai S; King C
    Transpl Infect Dis; 2019 Dec; 21(6):e13166. PubMed ID: 31487755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis versus pre-emptive treatment for prevention of cytomegalovirus infection in CMV-seropositive orthotopic liver-transplant recipients.
    Mengelle C; Rostaing L; Weclawiak H; Rossignol C; Kamar N; Izopet J
    J Med Virol; 2015 May; 87(5):836-44. PubMed ID: 25655981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interferon-gamma gene polymorphism +874 A/T is associated with an increased risk of cytomegalovirus infection among Hispanic renal transplant recipients.
    Vu D; Shah T; Ansari J; Sakharkar P; Yasir Q; Naraghi R; Hutchinson I; Min D
    Transpl Infect Dis; 2014 Oct; 16(5):724-32. PubMed ID: 25208755
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection.
    Chiereghin A; Potena L; Borgese L; Gibertoni D; Squarzoni D; Turello G; Petrisli E; Piccirilli G; Gabrielli L; Grigioni F; Lazzarotto T
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytomegalovirus infection associated accelerated heart allograft arteriosclerosis may impair the late function of the graft.
    Koskinen P; Lemstrøm K; Mattila S; Häyry P; Nieminen MS
    Clin Transplant; 1996 Dec; 10(6 Pt 1):487-93. PubMed ID: 8996768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytomegalovirus-related disease and risk of acute rejection in renal transplant recipients: a cohort study with case-control analyses.
    Toupance O; Bouedjoro-Camus MC; Carquin J; Novella JL; Lavaud S; Wynckel A; Jolly D; Chanard J
    Transpl Int; 2000; 13(6):413-9. PubMed ID: 11140239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of cytomegalovirus DNA levels with response to antiviral therapy in cardiac and renal allograft recipients.
    Toyoda M; Carlos JB; Galera OA; Galfayan K; Zhang X; Sun Z; Czer LS; Jordan SC
    Transplantation; 1997 Apr; 63(7):957-63. PubMed ID: 9112347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus infection in heart transplantation: A single center experience.
    Echenique IA; Angarone MP; Rich JD; Anderson AS; Stosor V
    Transpl Infect Dis; 2018 Aug; 20(4):e12896. PubMed ID: 29602266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute rejection and cardiac allograft vascular disease is reduced by suppression of subclinical cytomegalovirus infection.
    Potena L; Holweg CT; Chin C; Luikart H; Weisshaar D; Narasimhan B; Fearon WF; Lewis DB; Cooke JP; Mocarski ES; Valantine HA
    Transplantation; 2006 Aug; 82(3):398-405. PubMed ID: 16906040
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytomegalovirus infection in a seroendemic renal transplant population: a longitudinal study of virological markers.
    Rao M; Finny GJ; Abraham P; Juneja R; Thomas PP; Jacob CK; Sridharan G
    Nephron; 2000 Apr; 84(4):367-73. PubMed ID: 10754415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical usefulness of gene-expression profile to rule out acute rejection after heart transplantation: CARGO II.
    Crespo-Leiro MG; Stypmann J; Schulz U; Zuckermann A; Mohacsi P; Bara C; Ross H; Parameshwar J; Zakliczyński M; Fiocchi R; Hoefer D; Colvin M; Deng MC; Leprince P; Elashoff B; Yee JP; Vanhaecke J
    Eur Heart J; 2016 Sep; 37(33):2591-601. PubMed ID: 26746629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus infections in lung and hematopoietic cell transplant recipients in the Organ Transplant Infection Prevention and Detection Study: A multi-year, multicenter prospective cohort study.
    Avery RK; Silveira FP; Benedict K; Cleveland AA; Kauffman CA; Schuster MG; Dubberke ER; Husain S; Paterson DL; Chiller T; Pappas P
    Transpl Infect Dis; 2018 Jun; 20(3):e12877. PubMed ID: 29512935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytomegalovirus infection and ganciclovir resistance caused by UL97 mutations in pediatric transplant recipients.
    Kim YJ; Boeckh M; Cook L; Stempel H; Jerome KR; Boucek R; Burroughs L; Englund JA
    Transpl Infect Dis; 2012 Dec; 14(6):611-7. PubMed ID: 23198963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of cytomegalovirus infection with post-transplantation cardiac rejection as studied using the polymerase chain reaction.
    Fernando S; Booth J; Boriskin Y; Butcher P; Carrington D; Steel H; Tryhorn Y; Corbishley C; Keeling P; Murday A
    J Med Virol; 1994 Apr; 42(4):396-404. PubMed ID: 8046430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polymorphism in programmed cell death 1 gene is strongly associated with lung and kidney allograft survival in recipients from CMV-positive donors.
    Forconi C; Gatault P; Miquelestorena-Standley E; Noble J; Al-Hajj S; Guillemain R; Stern M; Hoffmann T; Prat L; Suberbielle C; Masson E; Cesbron-Gautier A; Gaudy-Graffin C; Goudeau A; Thibault G; Ivanes F; Guibon R; Kazma I; Lebranchu Y; Büchler M; Magnan A; Halimi JM; Baron C
    J Heart Lung Transplant; 2017 Mar; 36(3):315-324. PubMed ID: 27751774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of cytomegalovirus genotype with graft rejection after liver transplantation.
    Rosen HR; Corless CL; Rabkin J; Chou S
    Transplantation; 1998 Dec; 66(12):1627-31. PubMed ID: 9884250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease.
    Woo PC; Lo CY; Lo SK; Siau H; Peiris JS; Wong SS; Luk WK; Chan TM; Lim WW; Yuen KY
    Clin Diagn Lab Immunol; 1997 Sep; 4(5):515-8. PubMed ID: 9302197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of real time-polymerase chain reaction in determining cytomegalovirus viral DNA load in renal transplant recipients.
    Zhang CB; Lai HY; Xu HT; Wang DG; Xiao F
    Chin Med J (Engl); 2012 Oct; 125(19):3575-7. PubMed ID: 23044327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of cytomegalovirus in cardiac transplant recipients receiving induction immunosuppression with antithymocyte globulin.
    Jewani PK; Pouch SM; Kissling KT
    Clin Transplant; 2018 Nov; 32(11):e13420. PubMed ID: 30290013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of cytomegalovirus infection after treatment of acute rejection in renal transplant recipients.
    Jorgenson MR; Descourouez JL; Lyu B; Astor BC; Garg N; Smith JA; Mandelbrot DA
    Clin Transplant; 2019 Aug; 33(8):e13636. PubMed ID: 31194887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.